TGA approves Afluria Quad

28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine).

The TGA approved Afluria Quad (inactivated quadrivalent influenza vaccine (split virion)) on 22 July 2016 for use in persons aged 18 years and over for the prevention of influenza caused by influenza virus Types A and B contained in the vaccine.

Read TGA approval of Afluria Quad

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Australia , Vaccine , Influenza